Laporan Keuangan Ringkasan laba rugi, neraca, dan arus kas — INAF Indofarma Tbk.

Emiten
Tahun (s/d)
Periode
Satuan
 
Laba Rugi Neraca Arus Kas
INAF — Income Statement (Laba Rugi)
Dalam Jutaan IDR  |  Triwulanan  |  8 periode s/d 2025
IDX · Data asli: IDR
Dalam Jutaan IDR Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024
Total Pendapatan 151,551133,73567,02936,762210,380137,870109,71843,637
Total Beban Pokok Penjualan (170,767)(145,310)(76,989)(42,365)(247,887)(149,672)(108,385)(43,347)
Laba Kotor (19,217)(11,575)(9,961)(5,603)(37,508)(11,802)1,333291
Laba Kotor Setelah Ventura Bersama (18,750)(11,575)(9,961)(5,603)(36,996)(11,802)1,333291
Total Beban Usaha (102,333) (100,944) (30,812) (16,590) (230,845) (120,295) (75,374) (42,594)
Laba Usaha (121,083)(112,519)(40,773)(22,193)(267,840)(132,096)(74,041)(42,304)
Penghasilan/Beban Lain-Lain 49,627 (5,981) (3,520) (3,245) (15,918) (35,062) (28,062) (11,917)
Laba Sebelum Pajak (71,455)(118,500)(44,292)(25,438)(283,758)(167,158)(102,103)(54,220)
Beban Pajak Penghasilan (6,534) (8,591) 740 329 (50,734) 674 164 277
Laba Bersih Dari Operasi Yang Dilanjutkan (77,989)(127,091)(43,552)(25,109)(334,492)(166,484)(101,939)(53,944)
Hak Minoritas --------
Penyesuaian Proforma --------
Laba Bersih Tahun Berjalan (77,989)(127,091)(43,552)(25,109)(334,492)(166,484)(101,939)(53,944)
Pendapatan Komprehensif Lain - - - - (4,164) - - -
Jumlah Laba Komprehensif (77,989)(127,091)(43,552)(25,109)(338,656)(166,484)(101,939)(53,944)
Laba Bersih Yang Dapat Diatribusikan (77,989) (127,091) (43,552) (25,109) (334,492) (166,484) (101,939) (53,944)
Laba Komprehensif Yang Dapat Diatribusikan (77,989) (127,091) (43,552) (25,109) (338,656) (166,484) (101,939) (53,944)
Key Ratios — INAF ROE, ROA, EPS disetahunkan · Metode Teguh Hidayat · Harga saham: Rp 126 (2026-07-24)
Rasio Q4 2025 Q3 2025 ×1⅓ Q2 2025 ×2 Q1 2025 ×4 Q4 2024 Q3 2024 ×1⅓ Q2 2024 ×2 Q1 2024 ×4
Profitabilitas
Gross Margin (%) 12.68% 8.65% 14.86% 15.24% 17.83% 8.56% 1.22% 0.67%
Operating Margin (%) 79.90% 84.14% 60.83% 60.37% 127.31% 95.81% 67.48% 96.94%
Net Margin (%) 51.46% 95.03% 64.98% 68.30% 158.99% 120.75% 92.91% 123.62%
ROE (%) 11.03% 19.02% 10.79% 12.73% 29.24% 22.87% 22.50% 25.15%
ROA (%) 14.55% 29.14% 15.56% 17.50% 54.11% 29.27% 24.82% 27.24%
Per Lembar Saham
EPS (Rp) 25,16 54,68 28,10 32,41 107,93 71,62 65,78 69,62
BVPS (Rp) 228,10 287,47 260,51 254,56 369,13 313,18 292,35 276,86
Valuasi
PER (x) n/a n/a n/a n/a n/a n/a n/a n/a
PBV (x) n/a n/a n/a n/a n/a n/a n/a n/a
Struktur Modal
DER (x) 1.76x 1.65x 1.69x 1.73x 1.54x 1.78x 1.91x 1.92x